Greetings
Welcome to the pilot issue of 340B Report. We’re so glad to have you aboard! And now, let’s get to the news.
BREAKING: Drugmaker Xspire Owes 340B Refunds
Xspire Pharma, a privately held, specialty pharmaceutical company, owes refunds
…
Welcome to the pilot issue of 340B Report. We’re so glad to have you aboard! And now, let’s get to the news.
Xspire Pharma, a privately held, specialty pharmaceutical company, owes refunds
…